165 related articles for article (PubMed ID: 28894953)
1. Significant genetic association of a functional TFPI variant with circulating fibrinogen levels and coronary artery disease.
Naji DH; Tan C; Han F; Zhao Y; Wang J; Wang D; Fa J; Li S; Chen S; Chen Q; Xu C; Wang QK
Mol Genet Genomics; 2018 Feb; 293(1):119-128. PubMed ID: 28894953
[TBL] [Abstract][Full Text] [Related]
2. Single nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism.
Dennis J; Truong V; Aïssi D; Medina-Rivera A; Blankenberg S; Germain M; Lemire M; Antounians L; Civelek M; Schnabel R; Wells P; Wilson MD; Morange PE; Trégouët DA; Gagnon F
J Thromb Haemost; 2016 Oct; 14(10):1960-1970. PubMed ID: 27490645
[TBL] [Abstract][Full Text] [Related]
3. Association study to evaluate TFPI gene in CAD in Han Chinese.
Zhao Y; Yu Y; Shi M; Yang X; Li X; Jiang F; Chen Y; Tian X
BMC Cardiovasc Disord; 2017 Jul; 17(1):188. PubMed ID: 28716011
[TBL] [Abstract][Full Text] [Related]
4. Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives.
Harris GM; Stendt CL; Vollenhoven BJ; Gan TE; Tipping PG
Am J Hematol; 1999 Mar; 60(3):175-80. PubMed ID: 10072106
[TBL] [Abstract][Full Text] [Related]
5. The influence of tissue factor and tissue factor pathway inhibitor polymorphisms on thrombin generation in stable coronary artery disease.
Opstad TB; Pettersen AA; Bratseth V; Arnesen H; Seljeflot I
Pathophysiol Haemost Thromb; 2010; 37(2-4):98-103. PubMed ID: 21555871
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in antithrombin and in tissue factor pathway inhibitor genes are associated with recurrent pregnancy loss.
Guerra-Shinohara EM; Bertinato JF; Tosin Bueno C; Cordeiro da Silva K; Burlacchini de Carvalho MH; Pulcineli Vieira Francisco R; Zugaib M; Cerda A; Morelli VM
Thromb Haemost; 2012 Oct; 108(4):693-700. PubMed ID: 22918506
[TBL] [Abstract][Full Text] [Related]
7. Association of TFPI polymorphisms rs8176592, rs10931292, and rs10153820 with venous thrombosis: A meta-analysis.
Zhang Y; Pang A; Zhao L; Guo Q; Zhang Z; Zhu X; Wei R; Yin X; Wang B; Li X
Medicine (Baltimore); 2019 Mar; 98(12):e14978. PubMed ID: 30896671
[TBL] [Abstract][Full Text] [Related]
8. A Pilot Study of Tissue Factor-Tissue Factor Pathway Inhibitor Axis and Other Selected Coagulation Parameters in Broiler Chickens Administered in Ovo with Selected Prebiotics*.
Buzala M; Ponczek MB; Slomka A; Roslewska A; Janicki B; Zekanowska E; Bednarczyk M
Folia Biol (Krakow); 2016; 64(4):213-224. PubMed ID: 29809360
[TBL] [Abstract][Full Text] [Related]
9. Mechanism for shortening PT and APTT in dogs and rats--effect of fibrinogen on PT and APTT--.
Kurata M; Sasayama Y; Yamasaki N; Kitazawa I; Hamada Y; Horii I
J Toxicol Sci; 2003 Dec; 28(5):439-43. PubMed ID: 14746347
[TBL] [Abstract][Full Text] [Related]
10. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
[TBL] [Abstract][Full Text] [Related]
11. ADTRP regulates TFPI expression via transcription factor POU1F1 involved in coronary artery disease.
Luo C; Pook E; Wang F; Archacki SR; Tang B; Zhang W; Hu JS; Yang J; Leineweber K; Bechem M; Huang W; Song Y; Cheung SH; Laux V; Ke T; Ren X; Tu X; Chen Q; Wang QK; Xu C
Gene; 2020 Aug; 753():144805. PubMed ID: 32445923
[TBL] [Abstract][Full Text] [Related]
12. Genetic determinants of tissue factor pathway inhibitor plasma levels.
Dennis J; Kassam I; Morange PE; Trégouët DA; Gagnon F
Thromb Haemost; 2015 Aug; 114(2):245-57. PubMed ID: 25879386
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.
Mukherjee M; Ranlall N; Patel G; Rutlin A; Jehanli A; Kakkar VV
Blood Coagul Fibrinolysis; 2000 Apr; 11(3):285-91. PubMed ID: 10870809
[TBL] [Abstract][Full Text] [Related]
14. Underestimation of plasma level of factor V coagulant activity and fibrinogen concentration together with prolonged prothrombin time, activated partial thromboplastin time and thrombin time can result from pre-analytical very low calcium level in citrated sample tube.
d'Audigier C; Delassasseigne C; Robert A; Eschwège V
Int J Lab Hematol; 2016 Feb; 38(1):50-3. PubMed ID: 26406495
[TBL] [Abstract][Full Text] [Related]
15. The Levels of Tissue Factor Pathway Inhibitor in Sepsis Patients Receiving Prophylactic Enoxaparin.
Al Otair HA; Abdel Gader AG; Khurshid SM; Alzeer AH; Al Momen AK; Al Shaikh M; Al Gahtani F; Al Aseri ZA; Abdelrazik HA
Turk J Haematol; 2016 Jun; 33(2):112-8. PubMed ID: 26377606
[TBL] [Abstract][Full Text] [Related]
16. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
[TBL] [Abstract][Full Text] [Related]
17. Does hypertension confer a hypercoagulable state in stroke-prone spontaneously hypertensive rats?
Abumiya T; Sakata T; Enjyoji K; Kato H; Kawai J; Suzuki T; Masuda J; Sasaguri T; Ogata J
J Hypertens; 2000 Jul; 18(7):901-9. PubMed ID: 10930188
[TBL] [Abstract][Full Text] [Related]
18. Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.
Tinholt M; Vollan HK; Sahlberg KK; Jernström S; Kaveh F; Lingjærde OC; Kåresen R; Sauer T; Kristensen V; Børresen-Dale AL; Sandset PM; Iversen N
Breast Cancer Res; 2015 Mar; 17(1):44. PubMed ID: 25882602
[TBL] [Abstract][Full Text] [Related]
19. Norethisterone acetate alters coagulation gene expression in vitro in human cell culture.
Brosnan JF; Sheppard BL; Kelly LA; O'Leary JJ; Norris LA
Thromb Res; 2013 Jan; 131(1):72-7. PubMed ID: 22999413
[TBL] [Abstract][Full Text] [Related]
20. Hypocoagulable state of human preovulatory ovarian follicular fluid: role of sulfated proteoglycan and tissue factor pathway inhibitor in the fluid.
Shimada H; Kasakura S; Shiotani M; Nakamura K; Ikeuchi M; Hoshino T; Komatsu T; Ihara Y; Sohma M; Maeda Y; Matsuura R; Nakamura S; Hine C; Ohkura N; Kato H
Biol Reprod; 2001 Jun; 64(6):1739-45. PubMed ID: 11369603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
